Mutant p53 drives cancer cell migration by spatially reprogramming AP-1 transcriptional complexes at the FOSL1 locus, flipping the site’s transcriptional output to promote epithelial-mesenchymal transition. According to research published in Cell Death Discovery, the tumor suppressor p53 undergoes a dramatic functional switch upon mutation, acquiring oncogenic gain-of-function properties. Rather than performing its normal tumor-suppressive functions, the mutated protein actively drives the migratory behavior of cancer cells.
The study elucidates the molecular mechanisms underlying this transition by examining how wild-type p53 and mutant p53 differentially regulate epithelial-mesenchymal transition at the FOSL1 locus. In its wild-type form, p53 effectively suppresses epithelial-mesenchymal transition and silences FRA1 expression. It achieves this suppression by forming repressive complexes with the transcription factors c-JUN and ATF2 at cAMP response elements, known as CREs, located within intron 1 of the FOSL1 gene.
In sharp contrast, mutant p53 orchestrates a complete transcriptional switch at the same gene locus. The mutated protein redirects c-JUN and FRA1 complexes away from the intronic elements and onto TPA response elements, or TREs, positioned within the FOSL1 promoter. This spatial redirection establishes a self-reinforcing activation loop that activates transcription and directly propels pro-migratory progression.
This locus-specific reprogramming—shifting from enhancer-mediated suppression to promoter-driven activation—represents a novel gain-of-function mechanism through which mutant p53 co-opts AP-1 complexes to flip transcriptional output. The researchers conclude that these findings position the FOSL1 enhancer-promoter axis as a critical rheostat for controlling epithelial-mesenchymal transition. Furthermore, the work provides a mechanistic framework for targeting mutant p53-driven malignancies through the selective disruption of oncogenic AP-1 complexes, presenting potential therapeutic strategies against metastatic cancers.
Subject of Research: Mutant p53 regulation of AP-1 complexes and FOSL1 during epithelial-mesenchymal transition
Article Title: Spatial reprogramming of AP-1 complexes by mutant p53 flips the transcriptional output of the FOSL1 enhancer-promoter axis to drive migration
Article References: Hu, S., Wang, M., Ji, A., Gao, R., Sun, L., Li, X., & Zhang, Y. (2026). Spatial reprogramming of AP-1 complexes by mutant p53 flips the transcriptional output of the FOSL1 enhancer-promoter axis to drive migration. Cell Death Discovery. https://doi.org/10.1038/s41420-026-03463-7
Image Credits: AI Generated
DOI: 10.1038/s41420-026-03463-7
Keywords: mutant p53, wild-type p53, tumor suppressor, AP-1 complexes, FOSL1, FRA1, c-JUN, ATF2, epithelial-mesenchymal transition, gain-of-function, cancer cell migration, cAMP response elements, TPA response elements, promoter-driven activation, enhancer-mediated suppression, metastatic cancer, transcriptional reprogramming
News Source: Nathaniel Bowman. (November 22, 2026). Mutant p53 Reprograms AP-1 Complexes to Drive Cancer Cell Migration. Scienmag.



